Company Overview of Dermira Inc.
Dermira Inc., a development-stage biotech company, develops and commercializes therapies in dermatology. Its portfolio of dermatology therapeutics includes Lemuteporfin, a potent and selective topical photodynamic therapy for sebaceous gland disorders, including acne; DRM01, a topical sebum inhibitor targeting acne and sebaceous gland hyperactivity; and DRM02, a topical kinase inhibitor targeting inflammatory skin diseases. The company was founded in 2010 and is based in Redwood City, California. It has operations in Vancouver, Canada.
2055 Woodside Road
Redwood City, CA 94061
Founded in 2010
Key Executives for Dermira Inc.
Dermira Inc. Key Developments
Similar Private Companies By Industry
|TransGenex Nanobiotech, Inc.||United States|
|Roex Inc.||United States|
|Edenspace Systems Corporation||United States|
|X-Gen Pharmaceuticals, Inc.||United States|
|Cantrell Drug Company, Inc.||United States|
Recent Private Companies Transactions
March 28, 2013
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Citizens Budget Commission||United States|
Post a JobJobs
- Cayey | Becton DickinsonPosted: Dec 23
- Hyattsville, MD | University of Maryland University CollegePosted: Mar 04
- Boston, MA | VertexPosted: Mar 06
- Kansas City, KS | SkillsniperPosted: Feb 20
Sponsored Financial Commentaries
To contact Dermira Inc., please visit www.dermira.com. Company data is provided by Capital IQ. Please use this form to report any data issues.